Your browser doesn't support javascript.
loading
Extreme body mass index and survival in newly diagnosed multiple myeloma patients.
Shah, Urvi A; Whiting, Karissa; Devlin, Sean; Ershler, Rachel; Kanapuru, Bindu; Lee, David J; Tahri, Sabrin; Gwise, Thomas; Rustad, Even H; Mailankody, Sham; Lesokhin, Alexander M; Kazandjian, Dickran; Maura, Francesco; Auclair, Daniel; Birmann, Brenda M; Usmani, Saad Z; Gormley, Nicole; Marinac, Catherine R; Landgren, Ola.
Afiliación
  • Shah UA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. shahu@mskcc.org.
  • Whiting K; Department of Medicine, Weill Cornell Medical College, 400 East 67th Street, New York, NY, 10065, USA. shahu@mskcc.org.
  • Devlin S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, 1275 York Avenue, New York, NY, 10065, USA.
  • Ershler R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, 1275 York Avenue, New York, NY, 10065, USA.
  • Kanapuru B; Division of Hematologic Malignancies II, Center for Drug Evaluation and Research, U.S. Food, and Drug Administration, 5901-B Ammendale Road, Beltsville, MD, 20705-1266, USA.
  • Lee DJ; Division of Hematologic Malignancies II, Center for Drug Evaluation and Research, U.S. Food, and Drug Administration, 5901-B Ammendale Road, Beltsville, MD, 20705-1266, USA.
  • Tahri S; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
  • Gwise T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Rustad EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Mailankody S; Department of Hematology, Erasmus University Medical Center, 3000CA, Rotterdam, The Netherlands.
  • Lesokhin AM; Division of Biometrics IX, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 5901-B Ammendale Road, Beltsville, MD, 20705-1266, USA.
  • Kazandjian D; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379, Oslo, Norway.
  • Maura F; Department of Medicine, Lovisenberg Diaconal Hospital, 0456, Oslo, Norway.
  • Auclair D; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Birmann BM; Department of Medicine, Weill Cornell Medical College, 400 East 67th Street, New York, NY, 10065, USA.
  • Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Gormley N; Department of Medicine, Weill Cornell Medical College, 400 East 67th Street, New York, NY, 10065, USA.
  • Marinac CR; Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami, 1475 NW 12th Avenue, Miami, FL, 33136, USA.
  • Landgren O; Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami, 1475 NW 12th Avenue, Miami, FL, 33136, USA.
Blood Cancer J ; 13(1): 13, 2023 01 12.
Article en En | MEDLINE | ID: mdl-36631444
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos